Antitumor activity of high-density lipoproteins and their use for targeted drug delivery
Biomeditsinskaya Khimiya · 2026
DOI: 10.18097/pbmcr1720 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomeditsinskaya Khimiya, 2026. Verfasst von O N Poteryaeva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Federal Research Center for Fundamental and Translational Medicine, Research Institute of Biochemistry, Novosibirsk, Russia. Hauptthemen laut MEDLINE: Lipoproteins, HDL, Antineoplastic Agents, Neoplasms, Apolipoprotein A-I. Die Arbeit nennt 71 Literaturangaben.
Abstract (Originalsprache)
Blood levels of high-density lipoprotein (HDL) are significantly inversely correlated with the risk of numerous malignancies and overall mortality in most tumor types. This review focuses on the antitumor role of HDL and its main protein component, apolipoprotein A-I (apoA-I). The association of HDL/apoA-I with various cancer types and the probable mechanisms of their antitumor action, including cholesterol removal from tumor cells, modulation of the tumor microenvironment, and involvement in the regulation of oncogenic signaling pathways, are discussed. The identified high expression of the SR-B1 receptor in tumor cells supports the use of HDL and its synthetic analogs (apoA-I mimetics) as a platform for the targeted delivery of antitumor agents. Using various tumor models, it has been demonstrated that the use of these plasma components for targeted drug delivery enhanced their antitumor effect and reduced side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Federal Research Center for Fundamental and Translational Medicine, Research Institute of Biochemistry, Novosibirsk, Russia.
Zitieren
APA
Poteryaeva, O. N., Trifonova, N. V., & Usynin, I. F. (2026). Antitumor activity of high-density lipoproteins and their use for targeted drug delivery. Biomeditsinskaya Khimiya. https://doi.org/10.18097/pbmcr1720
Vancouver
Poteryaeva ON, Trifonova NV, Usynin IF. Antitumor activity of high-density lipoproteins and their use for targeted drug delivery. Biomeditsinskaya Khimiya. 2026. doi:10.18097/pbmcr1720
BibTeX
@article{Poteryaeva2026,
author = {Poteryaeva, O N and Trifonova, N V and Usynin, I F},
title = {Antitumor activity of high-density lipoproteins and their use for targeted drug delivery},
journal = {Biomeditsinskaya Khimiya},
year = {2026},
doi = {10.18097/pbmcr1720}
}
EUVIMED